PATENT CLAIM ANALYSIS

Application Number: 16122903
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "139100"]

Abstract:
Provided is a means for inhibiting a function of CD69, whereby allowing suppression of an inflammatory response. That is, provided are: a composition for treating an inflammatory disease which includes an antibody that specifically recognizes a myosin regulatory light chain polypeptide (hereinafter abbreviated as Myl), preferably Myl9, Myl12a, and Myl12b, and inhibits a result of an effect of coexistence of Myl with CD69; a method of treating an inflammatory disease, including administering, to a subject diagnosed as having an inflammatory disease, a therapeutically effective amount of the antibody; and a method of identifying a compound that inhibits a result of an effect of coexistence of Myl with CD69, and a method of identifying a candidate compound for treating an inflammatory disease, including selecting a compound that inhibits the result.

Claim (Index 16):
The method of treating an inflammatory disease according to  claim 13 , wherein the antibody is an antibody that specifically recognizes a partial amino acid sequence of Myl9, Myl12a, or Myl12b, and the partial amino acid sequence is the amino acid sequence of SEQ ID NO: 24.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 2.19403
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14893122', '15667644', '16063515', '14462424', '14021353']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7525735713614471
- 35 USC 102 Novelty (BERT): 0.6673424964810681
- Combined Prediction Score: 0.7440504638734092
- Mean Citation Score: 455.67147000000006
- Max Citation Score: 703.2145
- Similarity Product: 609.4069688979984

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test